Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions.
about
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infectionStimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyThe microbiome and HIV persistence: implications for viral remission and cure.
P2860
Antiretroviral therapy in HIV-infected elite controllers: impact on gut immunology, microbial translocation, and biomarkers of serious non-AIDS conditions.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@ast
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@en
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@nl
type
label
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@ast
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@en
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@nl
prefLabel
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@ast
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@en
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@nl
P2093
P2860
P1476
Antiretroviral therapy in HIV- ...... f serious non-AIDS conditions.
@en
P2093
Brendan J W Osborne
Colin Kovacs
Connie J Kim
Erika Benko
Feng-Yun Yue
Gabor Kandel
Kamnoosh Shahabi
Mario Ostowski
Sanja Huibner
P2860
P304
P356
10.1097/QAI.0000000000000359
P407
P577
2014-12-01T00:00:00Z